Navigation Links
Carbohydrate restriction may slow prostate tumor growth
Date:5/26/2009

DURHAM, N.C. -- Restricting carbohydrates, regardless of weight loss, appears to slow the growth of prostate tumors, according to an animal study being published this week by researchers in the Duke Prostate Center.

"Previous work here and elsewhere has shown that a diet light in carbohydrates could slow tumor growth, but the animals in those studies also lost weight, and because we know that weight loss can restrict the amount of energy feeding tumors, we weren't able to tell just how big an impact the pure carbohydrate restriction was having, until now," said Stephen Freedland, M.D., a urologist in the Duke Prostate Center and lead investigator on this study.

The researchers believe that insulin and insulin-like growth factor contribute to the growth and proliferation of prostate cancer, and that a diet devoid of carbohydrates lowers serum insulin levels in the bodies of the mice, thereby slowing tumor growth, Freedland said.

The findings appear in the May 26, 2009 online edition of the journal Cancer Prevention Research. Funding was provided by the United States Department of Veterans Affairs, the Department of Defense Prostate Cancer Research Program; the American Urological Association/ Foundation Astellas Rising Star in Urology Award, and the Robert C. Atkins Foundation.

Animals in the study were fed one of three diets: a very high fat/ no carbohydrate diet; a low-fat/ high carbohydrate diet; and a high fat/ moderate-carbohydrate diet, which is most similar to the "Western" diet most Americans eat, Freedland said. They were then injected with prostate tumors at the same time.

"The mice that were fed a no-carbohydrate diet experienced a 40 to 50 percent prolonged survival over the other mice," Freedland said.

Mice on the no-carbohydrate diet consumed more calories in order to keep body weights consistent with mice on the other study arms.

"We found that carbohydrate restriction withou
'/>"/>

Contact: Lauren Shaftel Williams
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Limiting refined carbohydrates may stall AMD progression
2. Researchers Pinpoint Link Between Caloric Restriction and Longevity
3. Fingertip Formulary Restrictions(TM) Provides Unprecedented Access to Real- Time Managed Care Restrictions Data
4. Food restriction increases dopamine receptor levels in obese rats
5. Government restrictions on weight loss surgeries limit access for poor, underinsured patients
6. AGA Institute applauds delay of Aetna sedation restrictions
7. Exercise and caloric restriction may be treatment method for metabolic syndrome
8. Calorie restriction limits and obesity fuels development of epithelial cancers
9. Calorie restriction limits Calorie restriction inhibits, obesity fuels development of epithelial can
10. Calorie restriction inhibits, obesity fuels development of epithelial cancers
11. NCPA Statement on Sense of Congress Resolution Opposing FDA Restrictions on Estriol Usage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Designed with the versatile ... to create an all new, exclusive line of supplementation ... with the latest and greatest, high impact, result driven ... be effective. The 24/7 Series can be used by ... even the casual fitness enthusiasts. There are no stimulant ...
(Date:5/29/2015)... The annual aesthetic meeting, put on by the American ... from May 14-19th. This global event sets a gold ... world; dedicating itself exclusively to cosmetic medicine. Dr. Paul ... to attend this year’s meeting. , Among the classes ... given the honor of sitting at the presenter’s table during ...
(Date:5/29/2015)... 2015 The report “Axillary ... comprehensive information on the therapeutic development for ... by identifying new targets and MOAs to ... on H1 2015 pipeline review of Axillary ... 13 figures, spread across 47 pages is ...
(Date:5/29/2015)... 29, 2015 External Counterpulsation, also known as ... treatment for patients. The Heart Fit Clinic is the first ... a raving review from patients who are now completing treatment. ... underwent 35 treatments of ECP treatment and received great results. ... Not only does the clinic perform this non-surgical treatment for ...
(Date:5/29/2015)... DISC, a method of behavioral analysis that explores ... by companies to improve hiring practices, streamline training, boost ... out-of-the-box practice, has now become an integral part of ... for Human Resource Management found that over 70% of ... an essential part of the hiring process, and a ...
Breaking Medicine News(10 mins):Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2Health News:PeopleKeys to Air a Follow-up to Their Popular DISC Trainer’s Toolbox Webinar, Featuring All-New Content and Strategies 2
... restrictive intellectual property laws devalue the "repurposing" of ... as life-saving treatments, a Portland researcher contends. , ... and behavioral neuroscience in the Oregon Health & ... Veterans Affairs Medical Center, writes in a letter ...
... Oct. 31 EntreMed, Inc.,(Nasdaq: ENMD ) ... of cancer and inflammatory diseases,announced today that James ... a Company overview at the Acumen BioFin Rodman ... at the New York Palace Hotel in,New York, ...
... Oct. 31 HearAtLast Inc. (Pink,Sheets: HRAL) announced today ... (NYSE: AXP ) and Wal-Mart Stores (NYSE: ... of a special American Express Giftcard,promotion. Starting November 15, ... when they purchase a hearing aid with,their American Express ...
... Oct. 31 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), ... small molecule therapeutics for,the treatment of cancer, today announced ... corporate overview at the 2007 Acumen BioFin Rodman &,Renshaw ... take place at 8:50 a.m. (Eastern) on,Tuesday, November 6, ...
... ... Margins Exceed 70 Percent, IRVINE, Calif., Oct. ... device company focused on the,development of minimally invasive technologies for ... procedures and increased gross margins resulted in a reduction,in operating ...
... Oct. 31 Ipsen,(Euronext: FR0010259150; IPN) and ... specialist in oncology and,serious medical conditions today ... exclusively in-licenses know-how and new patent,applications for ... the world excluding North America, and some ...
Cached Medicine News:Health News:Old drugs need 'repurposing' for new uses, physician says 2Health News:EntreMed to Present at the Rodman and Renshaw 9th Annual Healthcare Conference 2Health News:HearAtLast Teams Up with American Express and Wal-Mart to Conquer Hearing Loss 2Health News:HearAtLast Teams Up with American Express and Wal-Mart to Conquer Hearing Loss 3Health News:HearAtLast Teams Up with American Express and Wal-Mart to Conquer Hearing Loss 4Health News:Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference 2Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 2Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 3Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 4Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 5Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 6Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 7Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 8Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 9Health News:Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories 2Health News:Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories 3Health News:Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories 4Health News:Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories 5Health News:Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories 6
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ) has announced ... MRI Market - Growth, Trends And Forecasts (2014 - ... key players in the industry are GE , Hitachi ... Medical Systems MRI is a ... its higher sensitivity and use of non-ionizing radiations. Open ...
(Date:5/29/2015)... CAMBRIDGE, Massachusetts and SPARTANBURG, South ... The Guardian Research Network and Molecular Health have ... access and molecular diagnostic decision support to the majority ... The Guardian Research Network will collaborate with Molecular Health ... molecular testing to identify cohorts from hundreds of thousands ...
(Date:5/29/2015)... BRAINTREE, Mass. , May 29, 2015  Haemonetics ... Kent Davies , Chief Operating Officer, will present at ... New York on June 23 rd , ... public may access Mr. Davies, presentation live via webcast ... Haemonetics (NYSE: HAE ) is a global ...
Breaking Medicine Technology:North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... Reportlinker.com announces that a new market ... The Outlook for Pharmaceuticals ... Market growth in the mature ... the coming years by the health needs ...
... (Nasdaq: MSHL ), an oncology company focused ... metabolism, announced today that it has submitted an Investigational ... Drug Administration (FDA) to initiate clinical testing for oncology ... "I am extremely proud of our clinical ...
Cached Medicine Technology:The Outlook for Pharmaceuticals in Western Europe 2The Outlook for Pharmaceuticals in Western Europe 3The Outlook for Pharmaceuticals in Western Europe 4The Outlook for Pharmaceuticals in Western Europe 5Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344 2Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: